Physician profile
Brittany Stuart
NPI 1184366098
$9,163.02
in general payments reported to CMS, 2019-2025
36 companies · $2,835 in 2025
The $2,835 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $270 · 2023: $2,056 · 2024: $4,003 · 2025: $2,835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,098 · Travel and Lodging: $773 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,097.83 |
| Travel and Lodging | $772.90 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,097.73 | 2024-2025 | Infinity, Proclaim |
| Alnylam Pharmaceuticals INC. | $928.71 | 2022-2025 | Amvuttra, Onpattro |
| Alexion Pharmaceuticals, INC. | $905.38 | 2023-2025 | Ultomiris |
| Mdd US Operations, LLC | $827.70 | 2023-2025 | Gocovri, Gocovri |
| Teva Pharmaceuticals USA, INC. | $638.68 | 2023-2025 | Austedo Xr, Austedo Xr, Austedo |
| Biogen, INC. | $516.88 | 2022-2025 | Vumerity, Leqembi, Tysabri |
| Grifols USA, LLC | $496.45 | 2022-2025 | Gamunex-C |
| Abbvie INC. | $474.38 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $441.57 | 2023-2025 | Nuedexta, Rexulti |
| Xeris Pharmaceuticals, INC. | $402.84 | 2022-2025 | Keveyis |
| Sk Life Science, INC. | $355.00 | 2023-2025 | |
| Eisai INC. | $321.06 | 2022-2025 | |
| Amneal Pharmaceuticals LLC | $209.23 | 2022-2025 | Rytary, Crexont |
| Acadia Pharmaceuticals INC | $200.44 | 2023-2025 | Daybue, Nuplazid |
| Argenx US, INC. | $159.31 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $159.30 | 2023-2025 | Xeomin, Inbrija |
| Amgen INC. | $131.40 | 2025 | Krystexxa, Uplizna |
| Inspire Medical Systems, INC. | $103.52 | 2024 | Inspire |
| Ucb, INC. | $95.14 | 2022-2023 | Fintepla |
| Neurelis, INC. | $83.00 | 2023 | Valtoco |
| Lundbeck LLC | $76.92 | 2025 | Vyepti |
| Emd Serono, INC. | $74.08 | 2025 | Mavenclad |
| Genzyme Corporation | $65.90 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $64.12 | 2024-2025 | |
| Ipsen Biopharmaceuticals, INC | $49.12 | 2023-2025 | Dysport |
| Pfizer INC. | $47.66 | 2024-2025 | |
| Genentech USA, INC. | $31.75 | 2024 | Ocrevus |
| Neurocrine Biosciences, INC. | $28.62 | 2024 | Ingrezza |
| Lilly USA, LLC | $28.16 | 2023 | Amyvid |
| Kyowa Kirin, INC. | $28.08 | 2024 | Nourianz |
| Life Molecular Imaging LTD | $25.36 | 2025 | Neuraceq |
| Springworks Therapeutics, INC. | $24.58 | 2025 | Gomekli |
| Csl Behring | $21.12 | 2023 | Hizentra |
| Medtronic, INC. | $20.59 | 2024 | Percept PC Brainsense |
| Octapharma USA, INC. | $15.42 | 2023 | Panzyga |
| Avion Pharmaceuticals | $13.82 | 2023 | Dhivy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Stuart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.